Want to see AU:PYC full AI Analyst Report?
PYC Therapeutics Limited (PYC) Ratios
PYC Therapeutics Limited Ratios
AU:PYC's free cash flow for Q4 2026 was $-13.60M. For the 2026 fiscal year, AU:PYC's free cash flow was decreased by $-290.50K and operating cash flow was $-13.31M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 33.48 | 14.41 | 9.40 | 3.79 | 8.94 |
| Quick Ratio | 33.48 | 14.41 | 9.40 | 3.79 | 8.94 |
| Cash Ratio | 3.72 | 12.43 | 7.34 | 1.85 | 6.63 |
| Solvency Ratio | -2.78 | -3.71 | -3.60 | -2.51 | -2.53 |
| Operating Cash Flow Ratio | -3.09 | -4.19 | -4.24 | -2.91 | -4.96 |
| Short-Term Operating Cash Flow Coverage | -124.87 | 0.00 | -124.57 | -137.34 | -83.84 |
| Net Current Asset Value | $ 467.05M | $ 164.26M | $ 75.43M | $ 23.15M | $ 34.10M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.02 | 1.08 | 1.13 | 1.34 | 1.15 |
| Debt Service Coverage Ratio | -139.73 | -466.36 | -103.05 | -109.44 | -45.90 |
| Interest Coverage Ratio | -2043.25 | -861.87 | -789.64 | -1435.18 | -926.76 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.65 | 2.90 | 1.21 | 0.40 | 0.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 100.00% | 94.42% | 94.77% |
| EBIT Margin | 0.00% | -228.26% | -252.14% | -247.59% | -188.46% |
| EBITDA Margin | 0.00% | -223.51% | -247.30% | -242.01% | -183.23% |
| Operating Profit Margin | 0.00% | -228.26% | -176.15% | -247.77% | -188.29% |
| Pretax Profit Margin | 0.00% | -217.13% | -252.36% | -247.77% | -188.66% |
| Net Profit Margin | 0.00% | -214.11% | -171.02% | -144.18% | -86.41% |
| Continuous Operations Profit Margin | 0.00% | -117.13% | -172.76% | -147.77% | -89.10% |
| Net Income Per EBT | 62.13% | 98.61% | 67.77% | 58.19% | 45.80% |
| EBT Per EBIT | 84.39% | 95.12% | 143.27% | 100.00% | 100.20% |
| Return on Assets (ROA) | -6.12% | -27.45% | -41.35% | -61.32% | -30.57% |
| Return on Equity (ROE) | -6.25% | -29.67% | -46.87% | -82.12% | -35.23% |
| Return on Capital Employed (ROCE) | -11.91% | -31.37% | -47.31% | -136.17% | -73.74% |
| Return on Invested Capital (ROIC) | -7.47% | -16.88% | -32.15% | -80.22% | -34.39% |
| Return on Tangible Assets | -6.15% | -28.04% | -43.27% | -69.23% | -33.89% |
| Earnings Yield | -3.50% | -7.73% | -0.81% | -1.26% | -0.67% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.98 | 1.23 | 0.97 | 1.59 |
| Payables Turnover | 0.12 | 0.13 | 0.14 | 0.18 | 0.33 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 12.35 | 14.01 | 15.16 | 9.85 |
| Asset Turnover | 0.00 | 0.13 | 0.24 | 0.43 | 0.35 |
| Working Capital Turnover Ratio | 0.00 | 0.19 | 0.44 | 0.54 | 0.38 |
| Cash Conversion Cycle | -2997.67 | -2490.91 | -2275.11 | -1660.30 | -890.15 |
| Days of Sales Outstanding | 0.00 | 373.91 | 297.77 | 375.29 | 229.12 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 2997.67 | 2864.83 | 2572.87 | 2035.59 | 1119.27 |
| Operating Cycle | 0.00 | 373.91 | 297.77 | 375.29 | 229.12 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | -0.10 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.06 | -0.10 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -83.78 | -52.86 | -125.68 | -49.73 | -56.30 |
| Capital Expenditure Coverage Ratio | -83.78 | -52.86 | -125.68 | -49.73 | -56.30 |
| Operating Cash Flow Coverage Ratio | -71.23 | -50.36 | -34.68 | -77.41 | -23.08 |
| Operating Cash Flow to Sales Ratio | 0.00 | -2.19 | -1.75 | -1.55 | -1.36 |
| Free Cash Flow Yield | -3.64% | -8.07% | -0.83% | -1.38% | -1.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -28.55 | -13.00 | -123.96 | -79.07 | -149.48 |
| Price-to-Sales (P/S) Ratio | 0.00 | 27.69 | 211.99 | 114.01 | 129.17 |
| Price-to-Book (P/B) Ratio | 1.79 | 3.84 | 58.09 | 64.94 | 52.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -27.48 | -12.39 | -120.23 | -72.33 | -93.48 |
| Price-to-Operating Cash Flow Ratio | -27.81 | -12.62 | -121.19 | -73.79 | -95.14 |
| Price-to-Earnings Growth (PEG) Ratio | 0.70 | -0.01 | -3.34 | -1.26 | 6.09 |
| Enterprise Value Multiple | -14.55 | -9.50 | -84.52 | -46.71 | -69.54 |
| Enterprise Value | 1.19B | 498.63M | 4.61B | 1.79B | 2.04B |
| EV to EBITDA | -14.55 | -9.50 | -84.52 | -46.71 | -69.54 |
| EV to Sales | 0.00 | 21.22 | 209.01 | 113.04 | 127.42 |
| EV to Free Cash Flow | -26.31 | -9.49 | -118.54 | -71.72 | -92.21 |
| EV to Operating Cash Flow | -26.62 | -9.67 | -119.48 | -73.16 | -93.84 |
| Tangible Book Value Per Share | 0.94 | 0.33 | 0.02 | 0.01 | 0.01 |
| Shareholders’ Equity Per Share | 0.95 | 0.34 | 0.02 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.37 | 0.46 | 0.32 | 0.40 | 0.53 |
| Revenue Per Share | 0.00 | 0.05 | 0.01 | 0.00 | 0.00 |
| Net Income Per Share | -0.06 | -0.10 | -0.01 | -0.01 | -0.00 |
| Tax Burden | 0.62 | 0.99 | 0.68 | 0.58 | 0.46 |
| Interest Burden | 0.84 | 0.95 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 2.98 | 2.56 | 2.22 | 1.50 |
| SG&A to Revenue | 0.00 | 0.30 | 0.20 | 0.26 | 0.39 |
| Stock-Based Compensation to Revenue | 0.00 | 0.04 | 0.00 | -0.00 | 0.04 |
| Income Quality | 1.03 | 1.02 | 1.02 | 1.07 | 1.57 |
Currency in AUD